Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis (BRISK)

NCT06609343 is registered in ClinicalTrials.gov with The University of Texas Health Science Center at San Antonio as lead sponsor.

NCT NCT06609343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06609343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis (BRISK)
Lead sponsor
The University of Texas Health Science Center at San Antonio
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
August 24, 2026
Completion date
January 30, 2027
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, fatigue